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Abstract It has been proposed that gonadotropins
and/or gonadotropin releasing hormone (GnRH)
could be involved in the pathophysiology of the side
eVects after spaying in bitches, such as urinary inconti-
nence and an increased production of a woolly under-
coat. In order to provide tools to investigate the role of
these hormones in dogs we developed immunohisto-
chemical techniques and real-time RT-PCR to study
whether GnRH-, LH-, and FSH-receptors exist in
canine skin and urinary bladder. Tissue samples from
the skin of the Xank region and the ventral midline of
the urinary bladder from euthanised dogs were exam-
ined. We were able to quantify mRNA expression of
GnRH-, FSH-, and LH-receptors in canine skin and
bladder biopsies with a high primer eYcacy. Immuno-
histochemical studies showed that GnRH-, FSH-, and
LH-receptors are expressed in vessel walls, the epider-
mis, the hair follicle and in sebaceous and sweat glands
in canine skin and in transitional epithelium, and
smooth muscle tissue in the urinary bladder. Our data
provide the fundamentals to examine the distribution
of FSH-, LH-, and GnRH-receptors in canine skin and
urinary bladder and to assess gene activity at the tran-
scriptional level by real-time RT-PCR.
Keywords FSH receptor · LH-receptor · GnRH-
receptor · Canine · Skin · Urinary bladder
Introduction
Gonadotropin releasing hormone (GnRH) is a deca-
peptide that is secreted from the hypothalamus and
acts as an important regulator of endocrine and repro-
ductive functions (Kaiser et al. 1997). It binds to the
high aYnity GnRH-receptor (GnRHR) in the anterior
pituitary gland (Perrin et al. 1993) and stimulates the
synthesis and release of the pituitary gonadotropins
luteinizing hormone (LH) and follicle-stimulating hor-
mone (FSH), which regulate the mammalian reproduc-
tive process (Kakar et al. 1992). Studies have indicated
that GnRH can also eVect the secretion of hormones
and cell functions of nonpituitary tissues and its recep-
tor exists in other tissues such as ovary, testis, placenta,
adrenal, breast, and prostate gland (Jennes et al. 1988).
Luteinizing hormone binds to a transmembrane gly-
coprotein (LHR), which is a member of the G protein
coupled receptor family (Sun and Davies 1995). This
receptor plays a fundamental role in ovarian respon-
siveness to pituitary LH. Besides ovaries, LHR immu-
noreactivity was also found in other tissues, such as
brain, fallopian tube, endometrium, trophoblasts,
smooth muscle cells, skeletal muscle Wbres, Wbroblasts,
and resident tissue macrophages (Bukovsky et al.
2003). Furthermore, LHR have been described in
human skin (Pabon et al. 1996; Venencie et al. 1999).
Follicle-stimulating hormone which is required for
normal reproductive function in all mammals binds
like LH to a G protein coupled receptor (FSHR)
(Khan et al. 1997). FSHR are found on Sertoli cells in
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1989; Orth and Christensen 1977).
The interaction of FSH and LH with their receptors
stimulates the production of sex hormones, such as
estrogens, testosterons, and progesterons (Ashley et al.
1999). So far receptors for androgens (Blauer et al.
1991; Choudhry et al. 1992; Liang et al. 1993), estro-
gens (Hasselquist et al. 1980), and progesterone have
been described in the skin of human beings (Mow-
szowicz et al. 1982).
In bitches common side eVects of spaying are uri-
nary incontinence (Holt and ThrusWeld 1993) and an
increased production of a woolly undercoat, leading to
a so-called “puppy coat”(Scott et al. 2001). Until
recently all side eVects of spaying were thought to be
mainly due to an estrogen deWciency after ovarectomy.
However, estrogen deWciency has never been proven
as the underlying cause (Reichler et al. 2005; Scott
et al. 2001). There are some facts that do not support
estrogen deWciency as underlying cause. For the long-
term postponement of oestrus intact bitches are
treated with depot-gestagens, which results in ovarian
quiescence. Incontinence of the type seen in spayed
bitches has not been reported and rarely coat changes
do occur.
Some publications indicate that gonadotropins could
be involved in the pathophysiology of the side eVects
after spaying. After removal of the ovaries the negative
feedback of the gonadal hormones is interrupted. Thus
the plasma concentration of the gonadotropins
increases several folds (Olson and Nett 1992; Reichler
et al. 2005, 2004), a phenomenon which is also
observed in post-menopausal women (Wise 1999).
LHR have been demonstrated in hair follicles
(Pabon et al. 1996) and in the urinary bladder (Tao
et al. 1998) in human beings. A further indication that
the expression of LHR could play a role in the side
eVects after spaying and menopause, respectively, is
the fact that in urinary bladders of menopausal women
signiWcant lower mRNA levels for LHR were demon-
strated than in cycling women (Tao et al. 1998).
Furthermore, bitches which developed urinary inconti-
nence after spaying have signiWcantly lower GnRH
plasma levels than controls and treatment with GnRH
analogs proved to be curative (Reichler et al. 2003,
2005).
Based on this and in order to provide morphologic
and molecular biological evidence for further func-
tional studies in the dog we developed immunohisto-
chemical techniques and real-time RT-PCR to study
whether GnRH-, LH-, and FSH-receptors exist in
canine skin and urinary bladder and in which cells they
are localized.
Materials and methods
Tissues
Tissue samples from the skin of the Xank region and
the ventral midline of the urinary bladder from ten
freshly euthanised dogs between 4 and 11 years of
either sex were examined in this study. As positive con-
trol for the detection of the GnRHR and its mRNA
pituitary glands were used. Ovaries taken during spay-
ing were used as positive controls for LHR and FSHR.
Since it is for now unknown, which tissue does not
express any of these receptors we used cells from long-
term keratinocyte cultures as negative control, assum-
ing that receptor expression is negative after a
prolonged absence of endocrine stimuli.
For immunohistochemistry (IHC) biopsies and con-
trol tissue were Wxed in buVered formalin (4%) at
room temperature for 24 h. The biopsies and controls
were then embedded in paraYn wax and serial sections
of 4 m were cut from each tissue block.
Messenger RNA extracted from tissue samples,
which had been stored in RNAlater (Ambion; Cata-
logue No. 7020) at 4°C was analysed employing quanti-
tative real-time PCR.
mRNA extraction and quantitative real-time RT-PCR
Real-time RT-PCR was performed to quantify the pro-
duction of mRNA of GnRH-, LH-, and FSH-receptors.
The values were normalized using the housekeeping
gene ribosomal (r)18 S. Before RNA extraction, biop-
sies were homogenized with a Polytron PT 1,600E.
RNA extraction was performed according to the
instructions for the use of Quiagen RNeasy-Fibrous
Tissue Mini Kit (Quiagen). After extraction, RNA was
dissolved in 50 l of RNase-free water and the concen-
tration of puriWed total RNA was determined measur-
ing the optical density at 260 nm. Two g of each RNA
sample were reverse transcribed into cDNA using ran-
dom hexamer primers (Promega, Catalys AG; Wallis-
ellen, Switzerland) in a Wnal reaction volume of 50 l.
Primers and Xuorescent FAM-labeled probes were
designed in-house from published sequences using the
PrimerExpress software (Applied Biosystems, Foster
City, USA). The sequences of the primers and probes
are shown in Table 1. Real-time PCR was performed
using the TaqMan Universal PCR Master Mix (Invitro-
gen AG, Basel, Switzerland) with a concentration of
primers and probes of 1,000 and 200 nM, respectively
in a Wnal reaction volume of 25 l in an MX 4,000
(Stratagene) according to the manufacturer’s protocol.
PCR ampliWcation was performed for 50 cycles. PCR123
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was used as a measure of input RNA and thus to nor-
malize the mRNA levels. The results are expressed as
threshold cycle (CT), which is deWned as the cycle
number at which the PCR product crosses the thresh-
old of detection. They are calculated according to the
manufacturer’s protocol (User Bulletin No. 2, Applied
Biosystems). Threshold cycles lower than 40 were con-
sidered positive. Canine ovary and pituitary gland was
used as positive control tissue. Since it is not known
which tissue could serve as negative control we used
cultured keratinocytes instead. Control experiments
using RNA samples without reverse transcription were
performed to demonstrate absence of possible contam-
inating genomic DNA.
The obtained amplicons were sequenced to conWrm
homology with the respective sequence of the recep-
tors. In addition the sequences were blasted using the
basic local alignment search tool (BLAST) at the
National Center for Biotechnology Information
(NCBI), National Library of Medicine (http://www.
ncbi.nlm.nih.gov/cgi-bin/BLAST/Blast.cgi) to exclude
homologies with other sequences than the speciWc
receptors.
Immunohistochemistry
For IHC the following primary antibodies were used:
polyclonal goat anti human GnRH receptor (Santa
Cruz Biotechnology; Santa Cruz, CA, catalogue No. sc-
8682), polyclonal goat anti human LH receptor (Santa
Cruz Biotechnology; Santa Cruz, CA, catalogue No. sc-
26341), polyclonal rabbit anti-FSHr (Zymed Laborato-
ries Inc., San Francisco, CA, catalogue No. 18-2258).
As negative controls for the GnRH- and the LH-recep-
tor the respective blocking peptides (Santa Cruz Bio-
technology; Santa Cruz, CA, catalogue No. sc-8682 P
and No. sc-26341 P) were used. Rabbit IgG protein
(Zymed Laboratories Inc., San Francisco, CA, Cata-
logue No. 02-6102) was used as negative control for the
FSHR. For immunostaining of the FSHR the DakoCy-
tomation LSAB 2 System-HRP, code No. K0672 kit
was used.
After deparaYnzing and hydrating the sections they
were stained as follows:
FSHR Endogenous peroxidase was quenched by
incubating the section in H2O2 (diluted 1:10 in metha-
nol, 30 min). After rinsing in tap water slides were
blocked with BSA (0.5% in PBS/TBS, 30 min) before
the specimen was incubated with the primary antibody
(1:150 in PBS, overnight, 4°C). This step was followed
by sequential incubation with a biotinylated link anti-
body for 30 min and horseradish peroxidase streptavi-
din for 30 min. Staining was completed by incubation
with AEC Substrate-Chromogen for approximately
5 min. Between each incubation step slides were
washed twice for 5 min in PBS.
LHR Endogenous peroxidase was quenched by incu-
bating the section in 0.075% HCl in ethanol for 15 min.
After rinsing in tap water the slides were blocked with
horse serum (20% in TBS/Tween, 10 min) before the
specimen was incubated with the primary antibody
1:100 diluted in TBS/Tween, 30°C 70 min). This step
was followed by incubation with a mouse anti goat
horseradish peroxidase conjugate (1:150 in TBS/
Tween, 1 h). Staining was completed by incubation
with AEC Substrate-Chromogen for approximately
10 min. Between each incubation step slides were
washed twice for 5 min in TBS.
GnRHR Endogenous peroxidase was quenched by
incubating the section in H2O2 (1:10 in methanol,
15 min). After rinsing in tap water the slides were
blocked (0.5% BSA-PBS/TBS, 20 min) before the
Table 1 Sequences of primers and probes used for quantiWcation of mRNA production by real-time RT-PCR
Sequences of primers and probes for the canine hormone receptors were designed in-house from published sequences using the Primer-
Express software (Applied Biosystems, Rotkreuz, Switzerland). Primers and probe for the housekeeping gene r18 s (ribosomal RNA)
were purchased as predeveloped Control Reagents (Applera Europe B.V., Rotkreuz, Switzerland)
Canine hormone 
receptor
GeneBank accession 
number
Sequences of primers and probes Amplicon 
length
LH AF389885 5-AAACCAAAGGCCAGTATTATAACCA-3 (sense) 
5-AGTGAAAAAGCCAGCTGCACTAC-3 (antisense)
5-CCCACTCCCTGTCTGCCAGTCTATGG-3 (probe)
78 bp
FSH M65085 5-GTGGAGATTTTTCTCTGCAAATG -3 (sense)
5-CAGGAGCAGGGCCATAATT-3 (antisense)
5-TCATCCATCCACCTGCTTTCTTCCT-3 (probe)
71 bp
GnRH AF206513 5-TCTGCAAAGTCCTCAGCTATCTG-3 (sense)
5-GGCTGATCACTACCATCATGAAG-3 (antisense)
5-GCTTTTCTCCATGTATGCCCC-3 (probe)
74 bp123
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(1:40 diluted in PBS, 1 h 45 min). This step was fol-
lowed by incubation with a mouse anti goat horserad-
ish peroxidase conjugate (1:40 in PBS, 30 min).
Staining was completed by incubation with AEC Sub-
strate-Chromogen for approximately 20 min. Between
each incubation step slides were washed twice for
5 min in PBS.
Positive staining of all receptors resulted in a red-
colored precipitate at the antigen site. Slides were
counterstained with Ehrlichs hematoxylin and
mounted in GVA.
Results
Real-time RT PCR
For the Wrst time we were able to detect and quantify
mRNA of GnRH-, FSH-, and LH-receptors in canine
skin and bladder biopsies. Linearity of mRNA expres-
sion and primer eYcacy was assessed with serial dilu-
tions of the input amount of cDNA and is shown in the
standard curves of Figs. 1, 2 and 3 for GnRHR, LHR,
and FSHR, respectively. The homology of the obtained
amplicons with the respective sequence of the recep-
tors was conWrmed by DNA sequencing. Furthermore
we could prove with the Blast database search program
that the sequence of the GnRHR and LHR amplicons
showed a 100% homology with the respective hormone
receptors of the dog and a high homology with the
respective sequence of other species. The sequence of
the canine FSHR is not published yet and primers and
probes were designed from the known human
sequence. Homology of the obtained amplicon with
the human sequence was 97%. The amplicon of the
LHR was not only 100% homologous with the respec-
tive sequence of the canine receptor but also with some
bacterial and viral sequences (AF458082.1,
AF035003.2, AJ288592.1, AJ288588.1, AJ288587.1,
AJ288585.1, AY680862.1, AY429544.1, AJ431219.1,
AJ431214.1, AJ308478.1, AJ786617.1, AJ311600.1).
The mean and the range of the CT values of the skin
and urinary bladder biopsies as well as from the control
tissues are shown in Table 2.
Immunohistochemistry
Immunohistochemical studies showed that GnRH-,
FSH-, and LH-receptors are expressed in canine urinary
bladder and in canine skin. In the urinary bladder the
transitional epithelium and the smooth muscles are
labelled. Furthermore a positive staining for FSR recep-
tor was also seen in the connective tissue of the Lamina
propria. Positive cells show a diVuse cytoplasmic stain-
ing. Examples for positive staining and lack of staining in
negative controls in canine urinary bladder are depicted
in Fig. 4. All three hormone receptors are detectable in
the epidermis, the sebaceous- and sweat glands, as well
as in the arrector pili muscles. In the hair follicles positive
staining of all three receptors was noted in the infundibu-
lum and in the isthmus. No diVerence in the staining
intensity was noted between anagen and telogen follicles
in the above mentioned anatomic locations. The inner
Fig. 1 Linearity assessment of mRNA expression using serial
dilutions of input cDNA reverse transcribed from canine pitui-
tary gland
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Fig. 2 Linearity assessment of mRNA expression using serial
dilutions of input cDNA reverse transcribed from canine ovary
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Fig. 3 Linearity assessment of mRNA expression using serial
dilutions of input cDNA reverse transcribed from canine ovary
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Histochem Cell Biol (2006) 126:527–535 531root sheath of the upper portion of the bulb stains posi-
tively for GnRH- and LH-receptors, whereas the outer
root sheath stains for all three receptors. The lower por-
tion of the outer root sheath, the dermal papilla and the
matrix cells stain only for LHR. As in the urinary blad-
der positive cells show a diVuse cytoplasmic staining with
the exception of the glycogen rich cells outer root sheath
cells where positive labeling for GnRHR is marginating
the cytoplasmic membrane. Examples for positive stain-
ing and negative controls in canine skin are shown in
Fig. 5. Furthermore all three hormone receptors are
detectable in the muscular layer of the blood vessels in
urinary bladder and skin. Negative controls are negative
in the skin and the urinary bladder.
The intensity of the labeling within the cells and the
number of positively stained cells was graded semi-
quantitatively in the urinary bladder and the skin and is
scored as absent (¡), weak (+), moderate (++), and
strong (+++). In Table 3 the mean of the two obtained
values (Wnal score) is depicted.
Discussion
To our knowledge investigations of the distribution of
GnRH-, FSH-, and LH-receptors in canine skin and
urinary bladder have not been performed previously.
The present work demonstrates that mRNA for these
receptors is expressed in these tissues and that the cor-
responding proteins are present as well.
We were able to show that mRNA expression of
GnRH-, FSH-, and LH receptors can be quantiWed by
real-time PCR and that the sequence of the GnRHR
and LHR amplicons showed a 100% homology with
the respective hormone receptors of the dog. So far the
sequence of the canine FSHR is not published yet but
our amplicon shows a 97% homology with the human
receptor and a high primer eYcacy was shown in
canine tissue. Unfortunately the amplicon of the LHR
was not only 100% homologous with the respective
sequence of the canine receptor but also with some
bacterial and viral sequences. However, since we do
not expect these sequences in canine skin or urinary
bladder the real-time PCR can still be regarded as
highly speciWc.
Obtained CT values for the FSHR in the urinary
bladder were low in some tissue samples and negative
in others (range 36.06–50), although PCR performance
regarding sensitivity was appropriate as shown in the
positive control. These results suggest that individual
dogs do not express FSHR in the urinary bladder
which might be a consequence of a diVerent production
of primary regulatory hormones. Longterm keratino-
cytes were used as negative control for the real-time
PCR and CT values were negative for LHR and
FSHR. However, results were positive for GnRHR
suggesting that supraordinate hormones are still pro-
duced after prolonged cell culture.
Immunohistochemical studies showed that GnRH-,
FSH-, and LH-receptors were present in the skin. In
humans it has been demonstrated that LHR immu-
nolabeling is present in various epidermal structures.
In this human study in the epidermis the basal, spinous,
and granular cell layers were stained, whereas no
receptors were detected in the stratum corneum. In the
anagen hair, immunostaining was found in the inner
root sheath below the level of the sebaceous glands and
in the outer root sheath above this level. In the telogen
follicle, only the latter staining was observed. In the
sebaceous glands only the thin cells close to the walls of
the ducts were immunolabelled. In the ecrine sweat
glands, the external clear cells were stained in the
secretory portion of the gland, whereas only the cells
close to the lumen were stained in the ducts (Venencie
et al. 1999). Our Wndings on immunolabeling of the
LHR are in partial agreement with the Wndings in this
study. In our study we could demonstrate positive
labeling also in the outer root sheath of the upper bulb
and all sebocytes stained positively. Furthermore we
found positive staining for FSHR in the epidermis and
adnexa. In contrast monoclonal antibodies raised
against human FSHR failed to detect the latter in
Table 2 Mean and range of CT values of skin and bladder biopsies and controls
Tissue CT value and range
LHR FSHR GnRHR
Skin 33.57 (29.81–36.23) 37.89 (33.04–42.84) 36.08 (34.05–38.33)
Urinary bladder 31.12 (28.58–33.75) 44.73 (36.06–50.00) 34.94 (33.07–35.76)
Pituitary gland (positive control) 27.35 (26.43–28.37) 34.68 (31.69–37.40) 22.02 (20.67–23.07)
Ovary (positive control) 21.63 (19.79–26.97) 30.21 (28.51–31.86) 27.13 (23.58–28.79
Keratinocytes (negative control) 50 (50) 50 (50) 35.89 (34.64–37.13)123
532 Histochem Cell Biol (2006) 126:527–535human skin (Venencie et al. 1999). To our knowledge
no reports concerning GnRH-receptors in the skin
exist.
In the urinary bladder an intense labeling of the
transitional epithelium was observed with the antibody
raised against the LHR and a weak staining was pres-123
Histochem Cell Biol (2006) 126:527–535 533ent with antibodies against the FSH- and GnRH recep-
tors. All antibodies stained the smooth muscles in the
urinary bladder. It has been suggested that high LH
levels after menopause may be involved in increased
pelvic Xoor disorders, a common condition in postmen-
opausal women, since smooth muscles are an impor-
tant compartment of the pelvic Xoor (Brown et al.
1999). A further indication that the expression of LHR
Fig. 4  a Immunohistochemical labeling for the GnRH-receptor
in the urinary bladder. Note the moderate staining of the transi-
tional epithelium (small arrow) and the faint staining of the
smooth muscles (broad arrow). As indicated in the table muscles
located deeper in the bladder wall stained moderately (£100).
b Higher magniWcation of the transitional epithelium (£400).
c Higher magniWcation of the of the smooth muscles (£400).
d Negative control for the GnRH-receptor (£100). e Immunohis-
tochemical labeling for the LH-receptor in the urinary bladder.
Note the strong staining of the transitional epithelium (small ar-
row) and of the smooth muscles (broad arrow) (£100). f. Higher
magniWcation of the transitional epithelium (£400). g Higher
magniWcation of the of the smooth muscles (£400). h Negative
control for the LH-receptor (£100). i Immunohistochemical
labeling for the FSH-receptor in the urinary bladder. Note the ab-
sent staining of the transitional epithelium (small arrow) and the
absent to mild staining of the connective tissue of the Lamina
propria (broad arrow). As indicated in the table muscles located
deeper in the bladder wall stained mild to moderately (£100)
j. Higher magniWcation of the transitional epithelium (£400).
k Higher magniWcation of the smooth muscles (£400). l Negative
control for the FSH-receptor (£100)
Fig. 5 a Immunohistochemical labeling for the GnRH-receptor
in the canine skin. Note the strong staining of the upper portion
of the outer root sheath (arrow head), the sweat glands (small ar-
row) and the arrector pili muscle (curved arrow). Staining is ab-
sent in the hair bulb (broad arrow) b Negative control for the
GnRH-receptor (£100). c Immunohistochemical labeling for the
LH-receptor in the canine skin. Note the strong staining of the
upper portion of the outer root sheath (arrow head), the lower
portion of the outer root sheath (empty arrow), the sweat glands
(small arrow) and the arrector pili muscle (curved arrow). Stain-
ing is mild in the hair bulb (broad arrow) d Negative control for
the Lhreceptor (£100). e Immunohistochemical labeling for the
FSH-receptor in the canine skin. Note the moderate staining of
the upper portion of the outer root sheath (arrow head) and the
arrector pili muscle (curved arrow). Labeling is absent in the
sweat glands (small arrow) and the hair bulb (broad arrow). As
indicated in the table sweat glands in other areas stained mildly
positive. f Negative control for the FSH-receptor (£100)123
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menopause, respectively, is the fact that in urinary
bladders of menopausal women signiWcant lower
mRNA levels for LHR were demonstrated than in
cycling women (Tao et al. 1998). To our knowledge so
far no studies have been performed to demonstrate
GnRH-, and FSH receptors in the urinary bladder of
human beings.
Our data provide the fundamentals to examine the
distribution of FSH-, LH-, and GnRH-receptors in
canine skin and urinary bladder and to assess gene
activity at the transcriptional level by real-time RT-
PCR. This enables us in future studies to assess the
quantity of hormone receptors and the corresponding
histological changes in the skin and the urinary bladder
before and after spaying and thus gain more insight
into the pathogenesis of side eVects due to spaying.
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